Published in Exp Ther Med on March 08, 2017
Cell-cycle checkpoints and cancer. Nature (2004) 13.19
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet (2006) 7.01
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol (2000) 3.24
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res (2004) 2.39
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol (2013) 2.22
Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer (2012) 2.17
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer (2014) 1.93
Inhibition of proinflammatory cytokine production by pravastatin. Lancet (1999) 1.67
The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer (1998) 1.30
Radiosensitivity and fractionation response of crypt cells of mouse jejunum. Radiat Res (1969) 1.19
A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme. Am J Clin Oncol (1998) 1.17
Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother Oncol (2009) 1.14
Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res (2005) 1.10
Pravastatin limits radiation-induced vascular dysfunction in the skin. J Invest Dermatol (2009) 1.05
Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res (2007) 1.05
Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res (2008) 1.04
Radiation enteropathy--pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol (2014) 1.02
Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure. Radiat Res (2010) 1.01
Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis. QJM (2011) 1.00
No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer. Urology (2008) 1.00
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta (1990) 1.00
Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks. Clin Cancer Res (2006) 0.96
Timing of lethality from gastrointestinal syndrome in mice revisited. Int J Radiat Oncol Biol Phys (2009) 0.95
Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.90
Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol (2009) 0.89
Lovastatin causes sensitization of HeLa cells to ionizing radiation-induced apoptosis by the abrogation of G2 blockage. Int J Radiat Biol (2003) 0.88
Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection. Int J Radiat Oncol Biol Phys (2007) 0.87
Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis. J Neurooncol (2010) 0.85
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial. Eur J Cancer (2010) 0.84
Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo. Strahlenther Onkol (2008) 0.83
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer. Int J Radiat Oncol Biol Phys (2013) 0.81
Trametinib plus 4-methylumbelliferone exhibits antitumor effects by ERK blockade and CD44 downregulation and affects PD1 and PD-L1 in malignant pleural mesothelioma. J Thorac Oncol (2016) 0.78
Long-term sequential changes of radiation proctitis and angiopathy in rats. J Radiat Res (2012) 0.77
Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy. Oncol Lett (2013) 0.75
Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer. Mol Clin Oncol (2015) 0.75
Polaprezinc protects normal intestinal epithelium against exposure to ionizing radiation in mice. Mol Clin Oncol (2016) 0.75
Regnase-1 and Roquin Nonredundantly Regulate Th1 Differentiation Causing Cardiac Inflammation and Fibrosis. J Immunol (2017) 0.75